Singapore markets closed

Axonics Modulation Technologies, Inc. (0I3.MU)

Munich - Munich Delayed price. Currency in EUR
Add to watchlist
62.500.00 (0.00%)
At close: 08:05AM CEST
Full screen
Previous close62.50
Open62.50
Bid62.00 x N/A
Ask62.50 x N/A
Day's range62.50 - 62.50
52-week range44.20 - 63.50
Volume53
Avg. volume2
Market capN/A
Beta (5Y monthly)N/A
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
All
News
  • Business Wire

    Axonics Reports First Quarter 2024 Financial Results

    IRVINE, Calif., April 30, 2024--Axonics, Inc. (Nasdaq: AXNX), a medical technology company that develops and commercializes innovative and minimally invasive products to treat bladder and bowel dysfunction, today reported financial results for the three months ended March 31, 2024.

  • PR Newswire

    Boston Scientific Announces Results for First Quarter 2024

    Boston Scientific Corporation (NYSE: BSX) generated net sales of $3.856 billion during the first quarter of 2024, growing 13.8 percent on a reported basis, 15.0 percent on an operational1 basis and 13.1 percent on an organic2 basis, all compared to the prior year period. The company reported GAAP net income attributable to Boston Scientific common stockholders of $495 million or $0.33 per share (EPS), compared to $300 million or $0.21 per share a year ago, and achieved adjusted3 EPS of $0.56 for

  • Business Wire

    Axonics Stockholders Approve Merger Agreement with Boston Scientific

    IRVINE, Calif., March 22, 2024--Axonics, Inc. (Nasdaq: AXNX) announced that its stockholders have voted today to adopt Axonics’ merger agreement with Boston Scientific Corporation (NYSE: BSX). According to preliminary voting results from the special meeting of stockholders held earlier today, a majority of the shares of Axonics’ common stock outstanding and entitled to vote at the special meeting voted in favor of adopting the merger agreement. Final voting results, as tabulated by an independen